BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 28841289)

  • 1. Nanoscale Zeolitic Imidazolate Framework-8 as Efficient Vehicles for Enhanced Delivery of CpG Oligodeoxynucleotides.
    Zhang H; Chen W; Gong K; Chen J
    ACS Appl Mater Interfaces; 2017 Sep; 9(37):31519-31525. PubMed ID: 28841289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system.
    Hanagata N
    Int J Nanomedicine; 2012; 7():2181-95. PubMed ID: 22619554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.
    Takahashi H; Misato K; Aoshi T; Yamamoto Y; Kubota Y; Wu X; Kuroda E; Ishii KJ; Yamamoto H; Yoshioka Y
    Front Immunol; 2018; 9():783. PubMed ID: 29720976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graphene oxide-chitosan nanocomposites for intracellular delivery of immunostimulatory CpG oligodeoxynucleotides.
    Zhang H; Yan T; Xu S; Feng S; Huang D; Fujita M; Gao XD
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():144-151. PubMed ID: 28183591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polyethyleneimine-functionalized boron nitride nanospheres as efficient carriers for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
    Zhang H; Feng S; Yan T; Zhi C; Gao XD; Hanagata N
    Int J Nanomedicine; 2015; 10():5343-53. PubMed ID: 26346655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Template-Mediated Assembly of DNA into Microcapsules for Immunological Modulation.
    Qu Y; Ju Y; Cortez-Jugo C; Lin Z; Li S; Zhou J; Ma Y; Glab A; Kent SJ; Cavalieri F; Caruso F
    Small; 2020 Sep; 16(37):e2002750. PubMed ID: 32762023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanodelivery systems for enhancing the immunostimulatory effect of CpG oligodeoxynucleotides.
    Zhang H; Gao XD
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 2):935-946. PubMed ID: 27772724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycogen for lysosome-targeted CpG ODNs delivery and enhanced cancer immunotherapy.
    Zhang H; Lai L; Wang Z; Zhang J; Zhou J; Nie Y; Chen J
    Int J Biol Macromol; 2024 Feb; 257(Pt 1):128536. PubMed ID: 38061522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies.
    Hanagata N
    Int J Nanomedicine; 2017; 12():515-531. PubMed ID: 28144136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-organic frameworks of zeolitic imidazolate framework-7 and zeolitic imidazolate framework-60 for fast mercury and methylmercury speciation analysis.
    Xu F; Kou L; Jia J; Hou X; Long Z; Wang S
    Anal Chim Acta; 2013 Dec; 804():240-5. PubMed ID: 24267088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembly of poly-adenine-tailed CpG oligonucleotide-gold nanoparticle nanoconjugates with immunostimulatory activity.
    Chen N; Wei M; Sun Y; Li F; Pei H; Li X; Su S; He Y; Wang L; Shi J; Fan C; Huang Q
    Small; 2014 Jan; 10(2):368-75. PubMed ID: 23963797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG-oligodeoxynucleotides developed for grouper toll-like receptor (TLR) 21s effectively activate mouse and human TLR9s mediated immune responses.
    Yeh DW; Lai CY; Liu YL; Lu CH; Tseng PH; Yuh CH; Yu GY; Liu SJ; Leng CH; Chuang TH
    Sci Rep; 2017 Dec; 7(1):17297. PubMed ID: 29229937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An aluminum adjuvant-integrated nano-MOF as antigen delivery system to induce strong humoral and cellular immune responses.
    Zhong X; Zhang Y; Tan L; Zheng T; Hou Y; Hong X; Du G; Chen X; Zhang Y; Sun X
    J Control Release; 2019 Apr; 300():81-92. PubMed ID: 30826373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory Properties of Lipid Modified CpG Oligonucleotides.
    Yu C; An M; Li M; Liu H
    Mol Pharm; 2017 Aug; 14(8):2815-2823. PubMed ID: 28686452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silk Fibroin for CpG Oligodeoxynucleotide Delivery.
    Zhang H; Lai L; Wang Y; Ye B; Deng S; Ding A; Teng L; Qiu L; Chen J
    ACS Biomater Sci Eng; 2019 Nov; 5(11):6082-6088. PubMed ID: 33405662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly(ethylene glycol)-Mediated Assembly of Vaccine Particles to Improve Stability and Immunogenicity.
    Zhang G; Fu X; Sun H; Zhang P; Zhai S; Hao J; Cui J; Hu M
    ACS Appl Mater Interfaces; 2021 Mar; 13(12):13978-13989. PubMed ID: 33749241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hollow Zn/Co Zeolitic Imidazolate Framework (ZIF) and Yolk-Shell Metal@Zn/Co ZIF Nanostructures.
    Rösler C; Aijaz A; Turner S; Filippousi M; Shahabi A; Xia W; Van Tendeloo G; Muhler M; Fischer RA
    Chemistry; 2016 Mar; 22(10):3304-3311. PubMed ID: 26821605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminated yeast β-D-glucan for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced cancer immunotherapy.
    Zhang H; Wang Z; Wang S; Zhang J; Qiu L; Chen J
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126998. PubMed ID: 37729981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of Postmodified Zeolitic Imidazolate Framework-90 (ZIF-90) Nanocrystals: Correlation between Functionality and Toxicity.
    Yen CI; Liu SM; Lo WS; Wu JW; Liu YH; Chein RJ; Yang R; Wu KC; Hwu JR; Ma N; Shieh FK
    Chemistry; 2016 Feb; 22(9):2925-9. PubMed ID: 26756283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic Starch Nanoparticles for Enhancing CpG Oligodeoxynucleotide-Mediated Antitumor Immunity.
    Zhang J; Wang S; Huang H; Chen H; Chen J; Zhang H
    Biomacromolecules; 2023 Dec; 24(12):5898-5904. PubMed ID: 37957110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.